R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Introduction This paper aims to analyze the common-sized balance sheets and ratios of 12 companies in order to identify their respective industries (Please refer to the Appendix for an overview of the financial data). The balance sheets of the 12 companies are analyzed in four steps‚ as shown in the following table. Step Industry Common Characteristics Companies 1 Service Almost no inventories Inventory turnover negligible Major passenger airline Regional bank Temporary office
Premium Department store Retailing
Today the pharmaceutical industry is one of the biggest industries in the United States. The industry experienced a rapid growth rate (in the double digits) in the late 20th century which has now dropped into the single digits (Mullins‚ 2007). The global demand is driven by factors such as a worldwide increase in elderly population and a rising quality of life in developing nations. Time Magazine listed Generic Pharmaceutical Manufacturing as one of the top ten fastest growing industries in the United
Premium Pharmacology Pharmaceutical industry Pharmacy
Industry Analysis of pharmaceutical industry. Prepared for- Shahnoor lecturer Daffodil International University Prepared by- Name ID Ruhul Amin 113-11- MD. Tuammel Hossain 113-11-2190 Amina Afrin 113-11-2244 Arshad Pharmaceutical Industry of Bangladesh Abstract Pharmaceutical is the core of Bangladesh’s Healthcare
Premium Pharmaceutical industry Pharmacology Generic drug
underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic market of 150mn people‚ and nearly 3bn people in the Asian region that it has market access to. The aim of this paper is to provide global investors with an outline on the challenges and prospects for the Bangladesh economy as well as investment opportunities. The fact that
Premium Investment
Indian Pharmaceutical Industry Business Environment 3 Agenda • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage 4 History • Bengal Chemicals and Pharmaceutical Works‚ Calcutta‚ the first Indian pharmaceutical company established in 1901 • Still exists as one of the 5 government owned drug manufacturers • Next 60 years saw most of the drugs imported from multinationals 5 History
Premium Pharmaceutical industry Pharmacology Clinical trial
Strategic Analysis of the Global Automotive Industry This report provides an analysis and evaluation of common and major global trends and identifies the common business opportunities and their impact on the global automotive industry. Globalization gave the original equipment manufacturers (OEMs) not only the opportunity to expand to the new markets‚ but it also increased the risk of failure. Since globalization increased competition and gave the choice to consumers‚ automotive industry
Premium Automotive industry Customer Industry
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Ethics in the Pharmaceutical Industry The pharmaceutical industry started in the middle Ages‚ 18th AD in Baghdad in 754 by an Arabian. Until the early 70’s the industry grew at a small pace. In the 1970’s business began to boom and competition began to upsurge. In the 1990’s these industries and companies became more aggressive with their marketing strategies. In ’97 the U.S. Food and Drug Administration brought new rules and regulations concerning the marketing area and it required companies to
Premium Pharmacology Marketing Sales